Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT07547488
Recruiting Not applicable

Influence of Dressings on Skin pH Alterations in Simulated Skin Folds in Healthy Subjects

NCT07547488 · tracked via the Priya Life Science Sweden tracker
Sponsor
Essity Hygiene and Health AB
Phase
Not applicable
Started
2025-11-05
Last updated
2026-04-23

Condition(s) studied

Skin Folds

Investigational drug(s) / intervention(s)

Dressings

Dressings: Sorbact® Ribbon, Sorbact® Compress and InterDry®

Study summary

This study investigates the effect of different dressings on skin pH when applied to a simulated skin fold environment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Written informed consent to participate in this study 2. Healthy men and women between 18-80 years 3. Patient is mentally and physically able to participate in this study 4. Intact skin on the forearms without any signs of irritation 5. Agreed on not to shower or use cosmetic products on the arms the same day as visit 1 and during the study period 6. Agreed not to engage in intense physical activity throughout the study period Exclusion Criteria: 1. Skin disorder of any kind. 2. Known allergy to adhesives or/and any other component(silver) in the investigation devices. 3. Pregnant or lactating women. 4. Presence of tattoos on the forearms. 5. Ongoing medication with antibiotic. 6. Suffer from excessive sweating, hyperhidrosis.

Primary outcome measure(s)

  • Difference in skin pH — 24 hours of wear time
    Difference in skin pH between the simulated skin fold and the area under Sorbact® Compress, measured after approximately 24 hours of wear time

Trial sites (1)

FacilityCityRegionStatus
Essity Study site Mölndal Sweden Recruiting

More Essity Hygiene and Health AB trials in Sweden

Prospective, Explorative, Research Study with Women to Investigate Menstruation Leakage At Night Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07547488 on ClinicalTrials.gov ↗ ← All trials in Sweden